Infectious Diseases News and Research

RSS

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).

4 Nov 2004

Gene regulated by need to process proteins linked to enlargement of protein processing factory

Part of a cellular mechanism that regulates the folding of new proteins into their proper shapes also includes a genetic response that enlarges the factory where both protein folding and packaging of proteins occurs.

2 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004

New vaccines to counter biological agents such as anthrax

Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.

1 Nov 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Insects implicated in the evolution of new human infectious diseases

Insects and other invertebrates are the arena for the evolution of new infectious diseases in humans, new research shows.

25 Oct 2004

New understanding of how poxviruses jump from species to species

A Canadian study conducted at Robarts Research Institute sheds new light on how poxviruses can jump from species to species -- and will lead to further exploration of another potential candidate in the emerging field of “oncolytic viruses” to fight cancer.

25 Oct 2004

Microcrustaceans defeat dengue fever

Dengue fever causes 50 million infections annually in more than 90 countries; however this may soon become a thing of the past, as QIMR broadens its successful and totally environmentally-friendly mosquito-breeding control programs against dengue fever.

22 Oct 2004

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.

22 Oct 2004

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

FDA grants traditional approval for Fuzeon (enfuvirtide), to treat HIV

Roche and Trimeris today announced that the U.S. Food and Drug Administration (FDA) has granted traditional approval to Fuzeon (enfuvirtide), the first and only fusion inhibitor for the treatment of HIV.

18 Oct 2004

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Researchers from the Harvard School of Public Health have discovered what they believe is the fundamental mechanism within cells that links two fast-rising public health threats: obesity and Type 2 diabetes.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

SARS survivor to share his personal and professional experience of SARS

A Hong Kong SARS survivor who helped lead the territory's response to the disease from his hospital bed will be sharing his personal and professional experience of SARS at an international conference in Wellington next month.

13 Oct 2004

Infections among injecting drug users are a growing public health concern in the UK

New figures published by the UK's Health Protection Agency show that infections among injecting drug users (IDUs) are a growing public health concern.

13 Oct 2004

New study offers rare glimpse of how the smallpox virus attacks its victims

Results of a new study in monkeys offer scientists a rare glimpse of how, on a molecular level, the smallpox virus attacks its victims. The findings shed light on how the virus caused mass death and suffering, and will help point the way to new diagnostics, vaccines and drugs that would be needed in the event of a smallpox bioterror incident.

12 Oct 2004

Infectious Diseases News and Research

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Gene regulated by need to process proteins linked to enlargement of protein processing factory

$73 million to tackle infectious diseases such as West Nile virus and influenza

New vaccines to counter biological agents such as anthrax

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

New molecular tool to pinpoint DNA mutations among thousands of cells

Infectious diseases physicians call for financial incentives for industry

Insects implicated in the evolution of new human infectious diseases

New understanding of how poxviruses jump from species to species

Microcrustaceans defeat dengue fever

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

FDA grants traditional approval for Fuzeon (enfuvirtide), to treat HIV

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Malaria vaccine candidate looks extremely promising

SARS survivor to share his personal and professional experience of SARS

Infections among injecting drug users are a growing public health concern in the UK

New study offers rare glimpse of how the smallpox virus attacks its victims

Industry Focus: Infectious Diseases eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News